XLO – xilio therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Xilio Therapeutics Announces Pricing of Underwritten Offering
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
Xilio Therapeutics (NASDAQ:XLO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Xilio Therapeutics (NASDAQ:XLO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Xilio Therapeutics (NASDAQ:XLO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 424B5 Xilio Therapeutics, Inc.
Form DEF 14A Xilio Therapeutics, Inc. For: Feb 23
Form PRE 14A Xilio Therapeutics, Inc. For: Jan 16
Form 8-K Xilio Therapeutics, Inc. For: Jan 06
Form 4 Xilio Therapeutics, Inc. For: Dec 31 Filed by: Brennan Kevin M.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.